Operational EfficiencyGross margins continue to improve, reaching 33% during the quarter vs. 27% previously, as operating expenses decline significantly due to cost optimization measures.
Regulatory ProgressThe American Medical Association (AMA) has established a category I CPT code for the use of OGM in cytogenomic genome-wide analysis to detect structural and copy number variations related to hematological malignancies.
Technological AdvancementsThe continued rollout and upgrade cycle of BNGO's next-gen, higher-throughput Stratys system.